Cargando…

Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer’s Disease

Background: Alzheimer’s disease (AD) is a complex and severe neurodegenerative disease that still lacks effective methods of diagnosis. The current diagnostic methods of AD rely on cognitive tests, imaging techniques and cerebrospinal fluid (CSF) levels of amyloid-β1-42 (Aβ42), total tau protein and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Chun-Hung, Lin, Chieh-Hsin, Lane, Hsien-Yuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963160/ https://www.ncbi.nlm.nih.gov/pubmed/33803217 http://dx.doi.org/10.3390/ijms22052761

Ejemplares similares

d-glutamate and Gut Microbiota in Alzheimer’s Disease
por: Chang, Chun-Hung, et al.
Publicado: (2020)

Deep Learning with Neuroimaging and Genomics in Alzheimer’s Disease
por: Lin, Eugene, et al.
Publicado: (2021)

Brain Stimulation in Alzheimer's Disease
por: Chang, Chun-Hung, et al.
Publicado: (2018)

Machine Learning and Deep Learning for the Pharmacogenomics of Antidepressant Treatments
por: Lin, Eugene, et al.
Publicado: (2021)

Novel Therapeutic Approaches for Alzheimer’s Disease: An Updated Review
por: Yu, Tien-Wei, et al.
Publicado: (2021)

Novel Biomarkers of Alzheimer’s Disease: Based Upon N-methyl- D-aspartate Receptor Hypoactivation and Oxidative Stress
por: Chiang, Ting-I, et al.
Publicado: (2021)

Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment
por: Hung, Chung-Chieh, et al.
Publicado: (2021)

Precision Psychiatry Applications with Pharmacogenomics: Artificial Intelligence and Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2020)

Prediction of functional outcomes of schizophrenia with genetic biomarkers using a bagging ensemble machine learning method with feature selection
por: Lin, Eugene, et al.
Publicado: (2021)

Diagnosing Alzheimer’s Disease Specifically and Sensitively With pLG72 and Cystine/Glutamate Antiporter SLC7A11 AS Blood Biomarkers
por: Lane, Hsien-Yuan, et al.
Publicado: (2022)

d-Amino Acids and pLG72 in Alzheimer’s Disease and Schizophrenia
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer’s Disease
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Bupropion interferes with the image diagnosis of Parkinson’s disease
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Applying a bagging ensemble machine learning approach to predict functional outcome of schizophrenia with clinical symptoms and cognitive functions
por: Lin, Eugene, et al.
Publicado: (2021)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Trough Melatonin Levels Differ between Early and Late Phases of Alzheimer Disease
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Machine learning and systems genomics approaches for multi-omics data
por: Lin, Eugene, et al.
Publicado: (2017)

NMDA Neurotransmission Dysfunction in Behavioral and Psychological Symptoms of Alzheimer’s Disease
por: Huang, Yu-Jhen, et al.
Publicado: (2012)

Genetic Biomarkers on Age-Related Cognitive Decline
por: Lin, Chieh-Hsin, et al.
Publicado: (2017)

Characterization of Potential Protein Biomarkers for Major Depressive Disorder Using Matrix-Assisted Laser Desorption Ionization/Time-of-Flight Mass Spectrometry
por: Lin, Chieh-Hsin, et al.
Publicado: (2021)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Combination of G72 Genetic Variation and G72 Protein Level to Detect Schizophrenia: Machine Learning Approaches
por: Lin, Eugene, et al.
Publicado: (2018)

Systematic review: fluid biomarkers and machine learning methods to improve the diagnosis from mild cognitive impairment to Alzheimer’s disease
por: Blanco, Kevin, et al.
Publicado: (2023)

Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose‐finding, randomized, double‐blind, placebo‐controlled trial for Alzheimer's disease
por: Lane, Hsien‐Yuan, et al.
Publicado: (2022)

pLG72 levels increase in early phase of Alzheimer’s disease but decrease in late phase
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

A Novel Approach Utilizing Machine Learning for the Early Diagnosis of Alzheimer's Disease
por: Uddin, Khandaker Mohammad Mohi, et al.
Publicado: (2023)

Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach
por: Salvatore, Christian, et al.
Publicado: (2015)

An interpretable machine learning model for diagnosis of Alzheimer's disease
por: Das, Diptesh, et al.
Publicado: (2019)

Performances of Machine Learning Models for Diagnosis of Alzheimer’s Disease
por: Arjaria, Siddhartha Kumar, et al.
Publicado: (2022)

Exploiting machine learning models to identify novel Alzheimer’s disease biomarkers and potential targets
por: Alamro, Hind, et al.
Publicado: (2023)

Diagnosis and biomarkers of predementia in Alzheimer's disease
por: Forlenza, Orestes V, et al.
Publicado: (2010)

Biomarkers for Alzheimer’s Disease Early Diagnosis
por: Ausó, Eva, et al.
Publicado: (2020)

Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular De Novo Design, Dimensionality Reduction, and De Novo Peptide and Protein Design
por: Lin, Eugene, et al.
Publicado: (2020)

CSF Biomarkers for Alzheimer's Disease Diagnosis
por: Anoop, A., et al.
Publicado: (2010)

Hypothyroidism may exacerbate valproate-related hyperammonemic delirium
por: Hung, Chung-Chieh, et al.
Publicado: (2016)

Machine learning in diagnosis of coronary artery disease
por: Ling, Hao, et al.
Publicado: (2021)

Biomarkers for early diagnosis of Alzheimer disease: ‘ALZheimer ASsociated gene’– a new blood biomarker?
por: Jellinger, Kurt A, et al.
Publicado: (2008)

Potential Peripheral Biomarkers for the Diagnosis of Alzheimer's Disease
por: Patel, Seema, et al.
Publicado: (2011)

From Menopause to Neurodegeneration—Molecular Basis and Potential Therapy
por: Cheng, Yu-Jung, et al.
Publicado: (2021)

Molecular Basis of Late-Life Depression
por: Kuo, Chien-Yi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pf8d7qc7kj91qbto0vqfbvbj43